nodes	percent_of_prediction	percent_of_DWPC	metapath
Desogestrel—ESR1—LKB1 signaling events—ETV4—bone cancer	0.0593	0.0794	CbGpPWpGaD
Desogestrel—ESR1—Signaling events mediated by HDAC Class II—BCOR—bone cancer	0.0584	0.0781	CbGpPWpGaD
Desogestrel—Ethinyl Estradiol—NR1I2—bone cancer	0.0508	0.385	CrCbGaD
Desogestrel—PGR—Nuclear Receptors—NR1I2—bone cancer	0.0444	0.0595	CbGpPWpGaD
Desogestrel—PGR—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.0351	0.047	CbGpPWpGaD
Desogestrel—ESR1—Signaling events mediated by HDAC Class II—TUBB2A—bone cancer	0.0276	0.037	CbGpPWpGaD
Desogestrel—ESR1—Nuclear Receptors—NR1I2—bone cancer	0.0261	0.0349	CbGpPWpGaD
Desogestrel—Allylestrenol—CYP3A4—bone cancer	0.0216	0.164	CrCbGaD
Desogestrel—ESR1—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.0206	0.0276	CbGpPWpGaD
Desogestrel—PGR—Ovarian Infertility Genes—CDK4—bone cancer	0.0185	0.0247	CbGpPWpGaD
Desogestrel—PGR—Generic Transcription Pathway—ZNF77—bone cancer	0.0179	0.024	CbGpPWpGaD
Desogestrel—Etonogestrel—CYP3A4—bone cancer	0.0169	0.128	CrCbGaD
Desogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—ATF1—bone cancer	0.0167	0.0223	CbGpPWpGaD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—GNA11—bone cancer	0.0158	0.0212	CbGpPWpGaD
Desogestrel—ESR1—Estrogen Receptor Pathway—JUN—bone cancer	0.0143	0.0192	CbGpPWpGaD
Desogestrel—ESR1—FOXM1 transcription factor network—CHEK2—bone cancer	0.0139	0.0186	CbGpPWpGaD
Desogestrel—ESR1—Regulation of Telomerase—WT1—bone cancer	0.0136	0.0182	CbGpPWpGaD
Desogestrel—ESR1—Estrogen signaling pathway—BRAF—bone cancer	0.0125	0.0167	CbGpPWpGaD
Desogestrel—Levonorgestrel—CYP3A4—bone cancer	0.0119	0.0905	CrCbGaD
Desogestrel—ESR1—FOXM1 transcription factor network—BRCA2—bone cancer	0.0117	0.0157	CbGpPWpGaD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—IGF1R—bone cancer	0.0115	0.0154	CbGpPWpGaD
Desogestrel—Danazol—CYP3A4—bone cancer	0.0109	0.0824	CrCbGaD
Desogestrel—ESR1—Generic Transcription Pathway—ZNF77—bone cancer	0.0105	0.0141	CbGpPWpGaD
Desogestrel—Ethinyl Estradiol—CYP3A4—bone cancer	0.0101	0.0763	CrCbGaD
Desogestrel—Norethindrone—CYP3A4—bone cancer	0.00967	0.0733	CrCbGaD
Desogestrel—ESR1—Estrogen signaling pathway—JUN—bone cancer	0.00909	0.0122	CbGpPWpGaD
Desogestrel—ESR1—FOXM1 transcription factor network—CDK4—bone cancer	0.00871	0.0117	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—ZNF77—bone cancer	0.00862	0.0115	CbGpPWpGaD
Desogestrel—ESR1—FOXM1 transcription factor network—RB1—bone cancer	0.00758	0.0101	CbGpPWpGaD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—MMP2—bone cancer	0.00741	0.00992	CbGpPWpGaD
Desogestrel—ESR1—FOXM1 transcription factor network—MMP2—bone cancer	0.00727	0.00973	CbGpPWpGaD
Desogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—bone cancer	0.00721	0.00965	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.00705	0.00943	CbGpPWpGaD
Desogestrel—ESR1—ATF-2 transcription factor network—PLAU—bone cancer	0.00702	0.00941	CbGpPWpGaD
Desogestrel—PGR—Validated nuclear estrogen receptor alpha network—JUN—bone cancer	0.00683	0.00915	CbGpPWpGaD
Desogestrel—ESR1—ATF-2 transcription factor network—CDK4—bone cancer	0.00664	0.00889	CbGpPWpGaD
Desogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—JUN—bone cancer	0.0065	0.0087	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—PLAU—bone cancer	0.00613	0.0082	CbGpPWpGaD
Desogestrel—PGR—Generic Transcription Pathway—NR1I2—bone cancer	0.00606	0.00812	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.00593	0.00795	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.00579	0.00775	CbGpPWpGaD
Desogestrel—ESR1—ATF-2 transcription factor network—RB1—bone cancer	0.00577	0.00773	CbGpPWpGaD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—MMP9—bone cancer	0.00557	0.00746	CbGpPWpGaD
Desogestrel—ESR1—ATF-2 transcription factor network—MMP2—bone cancer	0.00554	0.00742	CbGpPWpGaD
Desogestrel—ESR1—FOXA1 transcription factor network—JUN—bone cancer	0.00541	0.00724	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—ATF1—bone cancer	0.00518	0.00693	CbGpPWpGaD
Desogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK4—bone cancer	0.00515	0.0069	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—ZNF77—bone cancer	0.00506	0.00678	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.00505	0.00676	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—KIT—bone cancer	0.00499	0.00669	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—CHEK2—bone cancer	0.00498	0.00667	CbGpPWpGaD
Desogestrel—Erythema nodosum—Epirubicin—bone cancer	0.00488	0.0402	CcSEcCtD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.00459	0.00615	CbGpPWpGaD
Desogestrel—Erythema nodosum—Doxorubicin—bone cancer	0.00452	0.0372	CcSEcCtD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—TGFBR2—bone cancer	0.00432	0.00578	CbGpPWpGaD
Desogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—bone cancer	0.00429	0.00574	CbGpPWpGaD
Desogestrel—ESR1—ATF-2 transcription factor network—JUN—bone cancer	0.00428	0.00573	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—BRCA2—bone cancer	0.00422	0.00565	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—FUS—bone cancer	0.00421	0.00564	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.00418	0.0056	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.00413	0.00553	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.0041	0.0055	CbGpPWpGaD
Desogestrel—ESR1—Validated nuclear estrogen receptor alpha network—JUN—bone cancer	0.00401	0.00537	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—MDM2—bone cancer	0.00393	0.00527	CbGpPWpGaD
Desogestrel—Fluid retention—Cisplatin—bone cancer	0.0039	0.0321	CcSEcCtD
Desogestrel—ESR1—Regulation of Telomerase—JUN—bone cancer	0.00382	0.00511	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—JUN—bone cancer	0.00373	0.005	CbGpPWpGaD
Desogestrel—Vaginal discharge—Methotrexate—bone cancer	0.00371	0.0305	CcSEcCtD
Desogestrel—ESR1—LKB1 signaling events—TP53—bone cancer	0.00364	0.00487	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—MMP9—bone cancer	0.00363	0.00486	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—NR1I2—bone cancer	0.00356	0.00476	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.0035	0.00468	CbGpPWpGaD
Desogestrel—Vaginal discharge—Epirubicin—bone cancer	0.00347	0.0286	CcSEcCtD
Desogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—bone cancer	0.00332	0.00445	CbGpPWpGaD
Desogestrel—Vaginal discharge—Doxorubicin—bone cancer	0.00321	0.0264	CcSEcCtD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—CDK4—bone cancer	0.00313	0.00419	CbGpPWpGaD
Desogestrel—ESR1—Regulation of Telomerase—EGFR—bone cancer	0.003	0.00402	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—KIT—bone cancer	0.00293	0.00393	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—NR1I2—bone cancer	0.00292	0.00391	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—BRAF—bone cancer	0.00277	0.00371	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—RB1—bone cancer	0.00272	0.00365	CbGpPWpGaD
Desogestrel—Breast disorder—Cisplatin—bone cancer	0.0027	0.0222	CcSEcCtD
Desogestrel—PGR—Signaling by ERBB4—EGFR—bone cancer	0.00269	0.0036	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.00259	0.00347	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—FUS—bone cancer	0.00247	0.00331	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—TP53—bone cancer	0.00246	0.0033	CbGpPWpGaD
Desogestrel—Breast pain—Epirubicin—bone cancer	0.00242	0.0199	CcSEcCtD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—MDM2—bone cancer	0.00232	0.00311	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—MDM2—bone cancer	0.00231	0.00309	CbGpPWpGaD
Desogestrel—Breast pain—Doxorubicin—bone cancer	0.00224	0.0184	CcSEcCtD
Desogestrel—PGR—Signaling Pathways—GRM4—bone cancer	0.00219	0.00293	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—RGS1—bone cancer	0.00219	0.00293	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—EIF2S1—bone cancer	0.00216	0.00289	CbGpPWpGaD
Desogestrel—Neoplasm—Methotrexate—bone cancer	0.00204	0.0168	CcSEcCtD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—JUN—bone cancer	0.00202	0.0027	CbGpPWpGaD
Desogestrel—Fluid retention—Epirubicin—bone cancer	0.002	0.0165	CcSEcCtD
Desogestrel—Eye disorder—Cisplatin—bone cancer	0.00193	0.0159	CcSEcCtD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.00192	0.00258	CbGpPWpGaD
Desogestrel—Neoplasm—Epirubicin—bone cancer	0.00191	0.0157	CcSEcCtD
Desogestrel—PGR—Signaling Pathways—GRM1—bone cancer	0.0019	0.00254	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—EZH2—bone cancer	0.00187	0.00251	CbGpPWpGaD
Desogestrel—Immune system disorder—Cisplatin—bone cancer	0.00186	0.0154	CcSEcCtD
Desogestrel—Fluid retention—Doxorubicin—bone cancer	0.00185	0.0153	CcSEcCtD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.00185	0.00248	CbGpPWpGaD
Desogestrel—Alopecia—Cisplatin—bone cancer	0.00182	0.015	CcSEcCtD
Desogestrel—Malnutrition—Cisplatin—bone cancer	0.0018	0.0148	CcSEcCtD
Desogestrel—Neoplasm—Doxorubicin—bone cancer	0.00177	0.0145	CcSEcCtD
Desogestrel—ESR1—Gene Expression—NR1I2—bone cancer	0.00171	0.00229	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.00167	0.00224	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—EGFR—bone cancer	0.00159	0.00212	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—EGFR—bone cancer	0.00158	0.00211	CbGpPWpGaD
Desogestrel—Mood swings—Methotrexate—bone cancer	0.00155	0.0128	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00152	0.0125	CcSEcCtD
Desogestrel—Migraine—Epirubicin—bone cancer	0.00151	0.0124	CcSEcCtD
Desogestrel—Affect lability—Epirubicin—bone cancer	0.00151	0.0124	CcSEcCtD
Desogestrel—Breast disorder—Methotrexate—bone cancer	0.00148	0.0122	CcSEcCtD
Desogestrel—Mood swings—Epirubicin—bone cancer	0.00145	0.012	CcSEcCtD
Desogestrel—Nervous system disorder—Cisplatin—bone cancer	0.00144	0.0118	CcSEcCtD
Desogestrel—Skin disorder—Cisplatin—bone cancer	0.00142	0.0117	CcSEcCtD
Desogestrel—Affect lability—Doxorubicin—bone cancer	0.0014	0.0115	CcSEcCtD
Desogestrel—Migraine—Doxorubicin—bone cancer	0.0014	0.0115	CcSEcCtD
Desogestrel—Breast disorder—Epirubicin—bone cancer	0.00139	0.0114	CcSEcCtD
Desogestrel—Mood swings—Doxorubicin—bone cancer	0.00134	0.0111	CcSEcCtD
Desogestrel—PGR—Signaling Pathways—SMO—bone cancer	0.00134	0.00179	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—TP53—bone cancer	0.00133	0.00178	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.00131	0.00176	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—GRM4—bone cancer	0.00128	0.00172	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—RGS1—bone cancer	0.00128	0.00172	CbGpPWpGaD
Desogestrel—Breast disorder—Doxorubicin—bone cancer	0.00128	0.0106	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Cisplatin—bone cancer	0.00127	0.0104	CcSEcCtD
Desogestrel—ESR1—Gene Expression—EIF2S1—bone cancer	0.00127	0.00169	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—GNA11—bone cancer	0.00122	0.00164	CbGpPWpGaD
Desogestrel—Weight increased—Epirubicin—bone cancer	0.00121	0.00993	CcSEcCtD
Desogestrel—Weight decreased—Epirubicin—bone cancer	0.0012	0.00987	CcSEcCtD
Desogestrel—PGR—Signaling Pathways—ATF1—bone cancer	0.00114	0.00152	CbGpPWpGaD
Desogestrel—Weight increased—Doxorubicin—bone cancer	0.00112	0.00919	CcSEcCtD
Desogestrel—ESR1—Signaling Pathways—GRM1—bone cancer	0.00111	0.00149	CbGpPWpGaD
Desogestrel—Weight decreased—Doxorubicin—bone cancer	0.00111	0.00913	CcSEcCtD
Desogestrel—PGR—Signaling Pathways—IL3—bone cancer	0.00111	0.00148	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.0011	0.00148	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—EZH2—bone cancer	0.0011	0.00147	CbGpPWpGaD
Desogestrel—Hypersensitivity—Cisplatin—bone cancer	0.00108	0.0089	CcSEcCtD
Desogestrel—Erythema multiforme—Methotrexate—bone cancer	0.00107	0.00882	CcSEcCtD
Desogestrel—Eye disorder—Methotrexate—bone cancer	0.00106	0.00872	CcSEcCtD
Desogestrel—Immune system disorder—Methotrexate—bone cancer	0.00102	0.00843	CcSEcCtD
Desogestrel—Diarrhoea—Cisplatin—bone cancer	0.001	0.00827	CcSEcCtD
Desogestrel—Erythema multiforme—Epirubicin—bone cancer	0.001	0.00826	CcSEcCtD
Desogestrel—Alopecia—Methotrexate—bone cancer	0.001	0.00825	CcSEcCtD
Desogestrel—Mental disorder—Methotrexate—bone cancer	0.000993	0.00818	CcSEcCtD
Desogestrel—Eye disorder—Epirubicin—bone cancer	0.000991	0.00816	CcSEcCtD
Desogestrel—Malnutrition—Methotrexate—bone cancer	0.000986	0.00812	CcSEcCtD
Desogestrel—Immune system disorder—Epirubicin—bone cancer	0.000958	0.00789	CcSEcCtD
Desogestrel—PGR—Signaling Pathways—TGFBR2—bone cancer	0.000948	0.00127	CbGpPWpGaD
Desogestrel—Alopecia—Epirubicin—bone cancer	0.000937	0.00772	CcSEcCtD
Desogestrel—Vomiting—Cisplatin—bone cancer	0.000933	0.00768	CcSEcCtD
Desogestrel—Mental disorder—Epirubicin—bone cancer	0.000929	0.00765	CcSEcCtD
Desogestrel—Erythema multiforme—Doxorubicin—bone cancer	0.000928	0.00764	CcSEcCtD
Desogestrel—Rash—Cisplatin—bone cancer	0.000925	0.00762	CcSEcCtD
Desogestrel—Dermatitis—Cisplatin—bone cancer	0.000924	0.00761	CcSEcCtD
Desogestrel—Malnutrition—Epirubicin—bone cancer	0.000923	0.0076	CcSEcCtD
Desogestrel—Eye disorder—Doxorubicin—bone cancer	0.000917	0.00755	CcSEcCtD
Desogestrel—PGR—Signaling Pathways—IGF1R—bone cancer	0.000892	0.00119	CbGpPWpGaD
Desogestrel—Immune system disorder—Doxorubicin—bone cancer	0.000886	0.0073	CcSEcCtD
Desogestrel—Nausea—Cisplatin—bone cancer	0.000871	0.00718	CcSEcCtD
Desogestrel—Alopecia—Doxorubicin—bone cancer	0.000867	0.00714	CcSEcCtD
Desogestrel—Mental disorder—Doxorubicin—bone cancer	0.00086	0.00708	CcSEcCtD
Desogestrel—Malnutrition—Doxorubicin—bone cancer	0.000854	0.00703	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000834	0.00687	CcSEcCtD
Desogestrel—Hypertension—Epirubicin—bone cancer	0.000797	0.00656	CcSEcCtD
Desogestrel—Nervous system disorder—Methotrexate—bone cancer	0.000789	0.0065	CcSEcCtD
Desogestrel—ESR1—Signaling Pathways—SMO—bone cancer	0.000785	0.00105	CbGpPWpGaD
Desogestrel—Skin disorder—Methotrexate—bone cancer	0.000782	0.00644	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00078	0.00643	CcSEcCtD
Desogestrel—Nervous system disorder—Epirubicin—bone cancer	0.000739	0.00608	CcSEcCtD
Desogestrel—Hypertension—Doxorubicin—bone cancer	0.000737	0.00607	CcSEcCtD
Desogestrel—Skin disorder—Epirubicin—bone cancer	0.000732	0.00603	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000722	0.00595	CcSEcCtD
Desogestrel—ESR1—Signaling Pathways—GNA11—bone cancer	0.000718	0.000961	CbGpPWpGaD
Desogestrel—Gastrointestinal disorder—Methotrexate—bone cancer	0.000695	0.00572	CcSEcCtD
Desogestrel—Nervous system disorder—Doxorubicin—bone cancer	0.000684	0.00563	CcSEcCtD
Desogestrel—Skin disorder—Doxorubicin—bone cancer	0.000677	0.00558	CcSEcCtD
Desogestrel—ESR1—Signaling Pathways—ATF1—bone cancer	0.000667	0.000893	CbGpPWpGaD
Desogestrel—Gastrointestinal pain—Methotrexate—bone cancer	0.000658	0.00542	CcSEcCtD
Desogestrel—ESR1—Signaling Pathways—IL3—bone cancer	0.000651	0.000871	CbGpPWpGaD
Desogestrel—Gastrointestinal disorder—Epirubicin—bone cancer	0.00065	0.00536	CcSEcCtD
Desogestrel—PGR—Signaling Pathways—KIT—bone cancer	0.000647	0.000866	CbGpPWpGaD
Desogestrel—Urticaria—Methotrexate—bone cancer	0.000639	0.00527	CcSEcCtD
Desogestrel—Abdominal pain—Methotrexate—bone cancer	0.000636	0.00524	CcSEcCtD
Desogestrel—Gastrointestinal pain—Epirubicin—bone cancer	0.000616	0.00507	CcSEcCtD
Desogestrel—PGR—Signaling Pathways—BRAF—bone cancer	0.000608	0.000814	CbGpPWpGaD
Desogestrel—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000602	0.00496	CcSEcCtD
Desogestrel—Urticaria—Epirubicin—bone cancer	0.000598	0.00493	CcSEcCtD
Desogestrel—Abdominal pain—Epirubicin—bone cancer	0.000596	0.0049	CcSEcCtD
Desogestrel—Hypersensitivity—Methotrexate—bone cancer	0.000593	0.00488	CcSEcCtD
Desogestrel—Gastrointestinal pain—Doxorubicin—bone cancer	0.00057	0.00469	CcSEcCtD
Desogestrel—ESR1—Signaling Pathways—TGFBR2—bone cancer	0.000556	0.000745	CbGpPWpGaD
Desogestrel—Hypersensitivity—Epirubicin—bone cancer	0.000555	0.00457	CcSEcCtD
Desogestrel—Urticaria—Doxorubicin—bone cancer	0.000554	0.00456	CcSEcCtD
Desogestrel—Abdominal pain—Doxorubicin—bone cancer	0.000551	0.00454	CcSEcCtD
Desogestrel—Diarrhoea—Methotrexate—bone cancer	0.000551	0.00454	CcSEcCtD
Desogestrel—ESR1—Signaling Pathways—IGF1R—bone cancer	0.000524	0.000701	CbGpPWpGaD
Desogestrel—Diarrhoea—Epirubicin—bone cancer	0.000515	0.00425	CcSEcCtD
Desogestrel—Hypersensitivity—Doxorubicin—bone cancer	0.000514	0.00423	CcSEcCtD
Desogestrel—Vomiting—Methotrexate—bone cancer	0.000512	0.00422	CcSEcCtD
Desogestrel—PGR—Signaling Pathways—MDM2—bone cancer	0.00051	0.000682	CbGpPWpGaD
Desogestrel—Rash—Methotrexate—bone cancer	0.000508	0.00418	CcSEcCtD
Desogestrel—Dermatitis—Methotrexate—bone cancer	0.000507	0.00418	CcSEcCtD
Desogestrel—Headache—Methotrexate—bone cancer	0.000504	0.00415	CcSEcCtD
Desogestrel—Vomiting—Epirubicin—bone cancer	0.000479	0.00394	CcSEcCtD
Desogestrel—Nausea—Methotrexate—bone cancer	0.000478	0.00394	CcSEcCtD
Desogestrel—Diarrhoea—Doxorubicin—bone cancer	0.000477	0.00393	CcSEcCtD
Desogestrel—Rash—Epirubicin—bone cancer	0.000475	0.00391	CcSEcCtD
Desogestrel—Dermatitis—Epirubicin—bone cancer	0.000475	0.00391	CcSEcCtD
Desogestrel—Headache—Epirubicin—bone cancer	0.000472	0.00389	CcSEcCtD
Desogestrel—Nausea—Epirubicin—bone cancer	0.000447	0.00369	CcSEcCtD
Desogestrel—Vomiting—Doxorubicin—bone cancer	0.000443	0.00365	CcSEcCtD
Desogestrel—PGR—Signaling Pathways—JUN—bone cancer	0.000443	0.000593	CbGpPWpGaD
Desogestrel—Rash—Doxorubicin—bone cancer	0.000439	0.00362	CcSEcCtD
Desogestrel—Dermatitis—Doxorubicin—bone cancer	0.000439	0.00362	CcSEcCtD
Desogestrel—Headache—Doxorubicin—bone cancer	0.000437	0.0036	CcSEcCtD
Desogestrel—PGR—Signaling Pathways—MMP9—bone cancer	0.000431	0.000577	CbGpPWpGaD
Desogestrel—Nausea—Doxorubicin—bone cancer	0.000414	0.00341	CcSEcCtD
Desogestrel—ESR1—Signaling Pathways—KIT—bone cancer	0.00038	0.000508	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—BRAF—bone cancer	0.000357	0.000478	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—EGFR—bone cancer	0.000348	0.000466	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MDM2—bone cancer	0.000299	0.0004	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—TP53—bone cancer	0.000292	0.000391	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—JUN—bone cancer	0.00026	0.000348	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MMP9—bone cancer	0.000253	0.000339	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—EGFR—bone cancer	0.000204	0.000274	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TP53—bone cancer	0.000172	0.00023	CbGpPWpGaD
